Global Anti-Hypertensive Drugs Market Report by TBRC covers anti-hypertensive drugs market size, drivers, restraints, key players, and the impact of COVID-19.
As per The Business Research Company’s “Anti-Hypertensive Drugs Global Market Report 2022”, the anti-hypertensive drugs market is expected to grow from $35.61 billion in 2021 to $37.47 billion in 2022 at a compound annual growth rate (CAGR) of 5.2%. The growth in the anti-hypertensive drugs global market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global anti-hypertensive drug market size is expected to reach $42.85 billion in 2026 at a CAGR of 3.4%. Sedentary lifestyle is a major driver for the growth of the anti-hypertensive drugs market.
Key Trends In The Anti-Hypertensive Drugs Market
Of late, there has been rise in use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of a hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When the two drugs are combined with different mechanisms of action, the effect is two to five times greater than monotherapy. Increasing the dose of monotherapy reduces coronary events by 29% and cerebrovascular events by 40%, while combining two antihypertensive agents with a different mechanism of action reduces coronary events by 40% and cerebrovascular events by 54%. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.
Overview Of The Anti-Hypertensive Drugs Market
The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services. These drugs are re used to prevent heart failure, kidney failure and acute stroke induced by hypertension. Some of the major anti-hypertensive drugs include diuretics, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor antagonists.